1. Home
  2. PTVE vs XENE Comparison

PTVE vs XENE Comparison

Compare PTVE & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTVE
  • XENE
  • Stock Information
  • Founded
  • PTVE 1880
  • XENE 1996
  • Country
  • PTVE United States
  • XENE Canada
  • Employees
  • PTVE N/A
  • XENE N/A
  • Industry
  • PTVE Containers/Packaging
  • XENE Biotechnology: Pharmaceutical Preparations
  • Sector
  • PTVE Consumer Discretionary
  • XENE Health Care
  • Exchange
  • PTVE Nasdaq
  • XENE Nasdaq
  • Market Cap
  • PTVE 3.1B
  • XENE 3.3B
  • IPO Year
  • PTVE 2020
  • XENE 2014
  • Fundamental
  • Price
  • PTVE $17.56
  • XENE $38.52
  • Analyst Decision
  • PTVE Hold
  • XENE Strong Buy
  • Analyst Count
  • PTVE 7
  • XENE 7
  • Target Price
  • PTVE $16.14
  • XENE $56.00
  • AVG Volume (30 Days)
  • PTVE 989.4K
  • XENE 424.9K
  • Earning Date
  • PTVE 02-27-2025
  • XENE 02-27-2025
  • Dividend Yield
  • PTVE 2.28%
  • XENE N/A
  • EPS Growth
  • PTVE N/A
  • XENE N/A
  • EPS
  • PTVE N/A
  • XENE N/A
  • Revenue
  • PTVE $5,197,000,000.00
  • XENE N/A
  • Revenue This Year
  • PTVE N/A
  • XENE N/A
  • Revenue Next Year
  • PTVE $1.80
  • XENE $1,600.08
  • P/E Ratio
  • PTVE N/A
  • XENE N/A
  • Revenue Growth
  • PTVE N/A
  • XENE N/A
  • 52 Week Low
  • PTVE $8.83
  • XENE $35.53
  • 52 Week High
  • PTVE $17.71
  • XENE $50.99
  • Technical
  • Relative Strength Index (RSI)
  • PTVE 79.77
  • XENE 42.98
  • Support Level
  • PTVE $17.41
  • XENE $36.90
  • Resistance Level
  • PTVE $17.71
  • XENE $41.03
  • Average True Range (ATR)
  • PTVE 0.11
  • XENE 1.41
  • MACD
  • PTVE -0.16
  • XENE 0.03
  • Stochastic Oscillator
  • PTVE 57.14
  • XENE 30.39

About PTVE Pactiv Evergreen Inc. Common stock

Pactiv Evergreen Inc is engaged in the business of manufacturing and distributing fresh foodservice and food merchandising products and fresh beverage cartons. It operates in two segments: Foodservice, Food and Beverage Merchandising. These segments manufacture products such as food containers, drinkware, tableware, service ware, ready-to-eat food containers, clear rigid-display containers, trays for meat and poultry, molded fiber egg cartons, printed cartons, spouts & filling machines, and other products. It generates the majority of its revenue from Food and Beverage Merchandising. The company's geographical segments are the United States, the Rest of North America, and Others, of which the vast majority of its revenue comes from the United States.

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.

Share on Social Networks: